Cargando…
Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells
CRISPR-Cas9 is quickly revolutionizing the way we approach gene therapy. CRISPR-Cas9 is a complexed, two-component system using a short guide RNA (gRNA) sequence to direct the Cas9 endonuclease to the target site. Modifying the gRNA independent of the Cas9 protein confers ease and flexibility to imp...
Autores principales: | Allen, Daniel, Rosenberg, Michael, Hendel, Ayal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525374/ https://www.ncbi.nlm.nih.gov/pubmed/34713240 http://dx.doi.org/10.3389/fgeed.2020.617910 |
Ejemplares similares
-
Editorial: CRISPR and beyond: Cutting-edge technologies for gene correction in therapeutic applications
por: Hendel, Ayal, et al.
Publicado: (2023) -
Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain
por: Nishizono, Hirofumi, et al.
Publicado: (2020) -
Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase
por: Ding, Xin-Yuan, et al.
Publicado: (2021) -
Protoplasts: From Isolation to CRISPR/Cas Genome Editing Application
por: Yue, Jin-Jun, et al.
Publicado: (2021) -
Strategies for delivery of CRISPR/Cas-mediated genome editing to obtain edited plants directly without transgene integration
por: Kocsisova, Zuzana, et al.
Publicado: (2023)